Epigenetic Therapies for Cancer
Publication type: Journal Article
Publication date: 2020-08-12
scimago Q1
wos Q1
SJR: 19.076
CiteScore: 96.4
Impact factor: 78.5
ISSN: 00284793, 15334406
PubMed ID:
32786190
General Medicine
Abstract
Epigenetic Therapies for Cancer Cancer-cell biology is dictated by alterations in epigenetic regulation of gene expression. Mechanisms underlying these regulators are increasingly being elucidated,...
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
2
4
6
8
10
12
14
16
|
|
|
Cancers
15 publications, 3.92%
|
|
|
International Journal of Molecular Sciences
11 publications, 2.87%
|
|
|
Frontiers in Cell and Developmental Biology
8 publications, 2.09%
|
|
|
Signal Transduction and Targeted Therapy
7 publications, 1.83%
|
|
|
European Journal of Medicinal Chemistry
7 publications, 1.83%
|
|
|
Journal of Medicinal Chemistry
7 publications, 1.83%
|
|
|
Frontiers in Immunology
6 publications, 1.57%
|
|
|
bioRxiv
6 publications, 1.57%
|
|
|
Clinical Epigenetics
4 publications, 1.04%
|
|
|
Cancer Letters
4 publications, 1.04%
|
|
|
Cell Reports
4 publications, 1.04%
|
|
|
Frontiers in Pharmacology
3 publications, 0.78%
|
|
|
Frontiers in Genetics
3 publications, 0.78%
|
|
|
Nature Communications
3 publications, 0.78%
|
|
|
Journal of Translational Medicine
3 publications, 0.78%
|
|
|
Seminars in Cancer Biology
3 publications, 0.78%
|
|
|
Bioorganic Chemistry
3 publications, 0.78%
|
|
|
MedComm
3 publications, 0.78%
|
|
|
Scientific Reports
3 publications, 0.78%
|
|
|
Blood
3 publications, 0.78%
|
|
|
Oncology Reports
2 publications, 0.52%
|
|
|
Cells
2 publications, 0.52%
|
|
|
Biomolecules
2 publications, 0.52%
|
|
|
Frontiers in Oncology
2 publications, 0.52%
|
|
|
British Journal of Cancer
2 publications, 0.52%
|
|
|
BMC Cancer
2 publications, 0.52%
|
|
|
Molecular Cancer
2 publications, 0.52%
|
|
|
Nature Reviews Clinical Oncology
2 publications, 0.52%
|
|
|
Cell Death and Disease
2 publications, 0.52%
|
|
|
2
4
6
8
10
12
14
16
|
Publishers
|
10
20
30
40
50
60
70
80
90
|
|
|
Elsevier
90 publications, 23.5%
|
|
|
Springer Nature
86 publications, 22.45%
|
|
|
MDPI
38 publications, 9.92%
|
|
|
Wiley
37 publications, 9.66%
|
|
|
Frontiers Media S.A.
25 publications, 6.53%
|
|
|
Cold Spring Harbor Laboratory
20 publications, 5.22%
|
|
|
American Chemical Society (ACS)
15 publications, 3.92%
|
|
|
Oxford University Press
6 publications, 1.57%
|
|
|
Spandidos Publications
5 publications, 1.31%
|
|
|
Taylor & Francis
5 publications, 1.31%
|
|
|
American Association for Cancer Research (AACR)
4 publications, 1.04%
|
|
|
American Society of Hematology
4 publications, 1.04%
|
|
|
Bentham Science Publishers Ltd.
3 publications, 0.78%
|
|
|
The Endocrine Society
3 publications, 0.78%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
3 publications, 0.78%
|
|
|
Royal Society of Chemistry (RSC)
3 publications, 0.78%
|
|
|
American Association for the Advancement of Science (AAAS)
3 publications, 0.78%
|
|
|
AME Publishing Company
3 publications, 0.78%
|
|
|
Portland Press
2 publications, 0.52%
|
|
|
American Society for Clinical Investigation
2 publications, 0.52%
|
|
|
Impact Journals
1 publication, 0.26%
|
|
|
Massachusetts Medical Society
1 publication, 0.26%
|
|
|
SAGE
1 publication, 0.26%
|
|
|
Xi'an Jiaotong University
1 publication, 0.26%
|
|
|
Public Library of Science (PLoS)
1 publication, 0.26%
|
|
|
Federation of American Societies for Experimental Biology (FASEB)
1 publication, 0.26%
|
|
|
MJS Publishing, Medical Journals Sweden AB
1 publication, 0.26%
|
|
|
Society for Translational Oncology
1 publication, 0.26%
|
|
|
European Molecular Biology Organization
1 publication, 0.26%
|
|
|
10
20
30
40
50
60
70
80
90
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
383
Total citations:
383
Citations from 2024:
129
(33.68%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
RIS
Copy
TY - JOUR
DO - 10.1056/NEJMra1805035
UR - https://doi.org/10.1056/NEJMra1805035
TI - Epigenetic Therapies for Cancer
T2 - New England Journal of Medicine
AU - Bates, S. D.
PY - 2020
DA - 2020/08/12
PB - Massachusetts Medical Society
SP - 650-663
IS - 7
VL - 383
PMID - 32786190
SN - 0028-4793
SN - 1533-4406
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2020_Bates,
author = {S. D. Bates},
title = {Epigenetic Therapies for Cancer},
journal = {New England Journal of Medicine},
year = {2020},
volume = {383},
publisher = {Massachusetts Medical Society},
month = {aug},
url = {https://doi.org/10.1056/NEJMra1805035},
number = {7},
pages = {650--663},
doi = {10.1056/NEJMra1805035}
}
Cite this
MLA
Copy
Bates, S. D.. “Epigenetic Therapies for Cancer.” New England Journal of Medicine, vol. 383, no. 7, Aug. 2020, pp. 650-663. https://doi.org/10.1056/NEJMra1805035.